Try our beta test site
2 studies found for:    am0010
Show Display Options
Rank Status Study
1 Recruiting Study of AM0010 With FOLFOX Compared to FOLFOX Alone Second-line Tx in Pts With Metastatic Pancreatic Cancer
Condition: Pancreatic Cancer
Interventions: Biological: AM0010;   Drug: FOLFOX
2 Active, not recruiting A Phase 1 Study of AM0010 in Patients With Advanced Solid Tumors
Conditions: Melanoma;   Prostate Cancer;   Ovarian Cancer;   Renal Cell Carcinoma;   Colorectal Carcinoma;   Pancreatic Carcinoma;   Non-small Cell Lung Carcinoma;   Solid Tumors;   Breast Cancer
Interventions: Drug: AM0010;   Drug: Paclitaxel or Docetaxel and Carboplatin or Cisplatin;   Drug: FOLFOX (Oxaliplatin/Leucovorin/5-Fluorouracil);   Drug: gemcitabine/nab-paclitaxel;   Drug: Capecitabine;   Drug: Pazopanib;   Drug: Pembrolizumab;   Drug: Paclitaxel;   Drug: nivolumab;   Drug: Gemcitabine/carboplatin

Study has passed its completion date and status has not been verified in more than two years.